Lobbyists Proudly Claim Responsibility for Medical Malpractice Reform Bill

There are two things you don’t want to see being made – sausage and legislation. ~ Otto von Bismarck. This axiomatic quote says it all: you don’t want to see these things being made because the process will likely turn your stomach. The latest effort by Washington’s true masters is no less disgusting. Lobbyists for the insurance and medical industries are proudly – and loudly – claiming responsibility for a recent medical malpractice reform bill.




Why Aren’t Patients Paying Their Hospital Bills?

According to recent studies, including one from “TransUnion, a company that helps hospitals collect unpaid bills,” more and more people are failing to pay off their entire hospital bills. In fact, according to TransUnion, “more than two-thirds of patients aren’t paying” off their bills, “and that number could increase to 95 percent by 2020.”


Franciscan Health Agrees to $15M Settlement in Medical Malpractice Case

When many parents head to the hospital for the birth of a child, they do so with the expectation that they will be leaving with a happy, healthy, bouncing baby. The last thing on their minds is that the hospital staff will make a life changing mistake. This was the unfortunate reality for one Sauk Village family. Fortunately, a settlement has finally been reached between the family of Nyelle Brown and Franciscan St. James Health in Chicago Heights. The case settled for $15 million and was the result of a medical malpractice lawsuit filed against the health center back in 2013 in response to the severe brain damage Nyelle suffered during her birth in January 2011.



Tight Deadlines for Plaintiffs NOT Enrolling in the Benicar Settlement Program

As reported Monday, a $300M settlement agreement was reached between Daiichi Sankyo and users of the popular high blood pressure drug, Benicar. The settlement agreement may be read on a website, Olmesartan Products Litigation Settlement, established to facilitate payment of claims. Plaintiffs opting to enroll in the Olmesartan Products Resolution Program (at the website) must comply with enrollment requirements as spelled out on the site.


Breaking News: Parties Reach $300M Settlement in Benicar MDL

Almost two and a half years after the Judicial Panel on Multidistrict Litigation (JPML) created the Benicar MDL, the parties reached a $300M settlement. At issue was whether the manufacturers, Daiichi Sankyo and Forest Laboratories, knew or should have known and failed to warn consumers that Benicar, a popular high blood pressure medication, may cause